Bitesize Bio's Vicki Ronaldson this week says that "despite the temptation to play down past academic pursuits amongst more corporate peers, a look at the top level management, or even the board, of any global life science or technology company will reveal a high percentage of PhDs, all of whom started out at the bench." But, she says, transitioning from academic research to the corporate world can be tough.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.